FDA warned Chinese device maker Qianjiang Kingphar that dirty cleanrooms and weak environmental controls make its masks, dressings, wraps and drapes adulterated.
What happened
FDA inspected the Qianjiang, China plant from June 30 to July 3, 2025. Investigators saw dirt and filth on cleanroom floors and walls, peeling floor molding, and cleaning logs that recorded surfaces as clean when they were not. FDA also found the firm had no alert or action limits for airborne and microbial particle counts in its ISO 8 cleanrooms and no clear rules for handling out-of-limit results.
What FDA found
The firm did not keep up procedures to stop equipment or product from being contaminated, and its cleanroom cleaning records were inaccurate.
21 CFR 820.70(e)The firm did not set alert and action limits for particle and microbial counts in its cleanrooms and had no clear steps for what to do when limits are exceeded.
21 CFR 820.70(c)
What FDA wants
FDA wants a written reply within 15 business days describing the specific fixes and corrective actions, including a timetable and steps to prevent repeat problems, plus English translations of any documents not in English.
Who should pay attention
- brands and distributors that buy finished devices from this contract manufacturer
- sterile-barrier packaging and wound care companies sourcing from China
- quality teams running ISO 8 cleanrooms for medical devices
This is a summary. Read the original letter on fda.gov.